Marshall Stoller
For four decades, Dr. Marshall Stoller has shaped the field of urology—transforming how we treat kidney stones, training the next generation of specialists, and driving innovation that has impacted countless lives around the world. As a professor of Urology at the University of California San Francisco (UCSF), his contributions to research, education, and patient care have forever changed the institution, the field of urology, and the thousands of patients he has cared for.
Dr. Stoller started the Endourology Division at UCSF in 1987 and was instrumental in advancing technologies such as extracorporeal shock wave lithotripsy, reusable and disposable flexible ureteroscopes, and robotic-assisted surgery. His research into stone formation, including mapping Randall plaques and understanding the link between kidney stones and cardiovascular health, has redefined how specialists approach treatment. His early studies with lemon juice are now used around the world to help prevent stone recurrence. His collaborations with Stanford and Caltech led to revolutionary new technologies, including microbubble therapy, which is now in clinical trials. He has more than 25 patents on a variety of areas.
Beyond his research, Dr. Stoller has mentored over 100 residents and 35 fellows, many of whom have become leaders in the field. His teaching has been recognized with multiple awards, including the AUA Urology Care Foundation Distinguished Mentor Award and UCSF’s Distinction in Teaching Award for two separate years. His passion for mentorship is evident in his hands-on approach, guiding trainees not just in technical skills but in thinking critically and compassionately about patient care.
Dr. Stoller’s commitment to innovation is reflected in his collaborations across multiple disciplines. Partnering with UCSF’s School of Dentistry, he investigated the role of mineralization in the renal papilla, leveraging advanced imaging techniques to visualize stone formation. He also worked with the Buck Institute on Aging, using a fruit fly model to study the role of zinc in stone formation. His ability to bridge medicine, engineering, and basic science has led to groundbreaking discoveries that continue to shape the field of urology today. He is presently a PI of a large interinstitutional NIH grant (UCSF, UC Berkeley, UC Davis and Stanford) to help fund research in benign disease including urology, nephrology and hematology.
Dr. Stoller has received many prestigious awards, including the Endourological Society’s Karl Storz Lifetime Achievement Award. He is known for his curiosity, dedication, and a relentless pursuit of better treatments for patients suffering from kidney stones and other urological conditions.
17th August 2025
| Time | Session |
|---|---|
|
08:30
10:00
|
TICC - 3F Plenary Hall
|